1. Home
  2. MAR vs BSX Comparison

MAR vs BSX Comparison

Compare MAR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marriott International

MAR

Marriott International

HOLD

Current Price

$357.72

Market Cap

83.2B

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$63.00

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAR
BSX
Founded
1927
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.2B
93.4B
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
MAR
BSX
Price
$357.72
$63.00
Analyst Decision
Buy
Strong Buy
Analyst Count
16
21
Target Price
$346.63
$102.19
AVG Volume (30 Days)
1.3M
14.3M
Earning Date
05-06-2026
04-22-2026
Dividend Yield
0.75%
N/A
EPS Growth
14.17
55.20
EPS
9.51
1.94
Revenue
$26,186,000,000.00
$9,076,000,000.00
Revenue This Year
$304.41
$11.91
Revenue Next Year
$5.36
$10.26
P/E Ratio
$37.81
$32.46
Revenue Growth
4.33
12.49
52 Week Low
$212.53
$60.59
52 Week High
$370.00
$109.50

Technical Indicators

Market Signals
Indicator
MAR
BSX
Relative Strength Index (RSI) 66.76 35.16
Support Level $312.30 N/A
Resistance Level $370.00 $76.77
Average True Range (ATR) 8.02 1.77
MACD 3.91 0.04
Stochastic Oscillator 99.64 22.48

Price Performance

Historical Comparison
MAR
BSX

About MAR Marriott International

Marriott operates 1.8 million rooms across roughly 30 brands. At the end of 2025, luxury represented roughly 10% of total rooms, premium was 42%, select service was 46%, and midscale was 2%. Marriott, Courtyard, and Sheraton are the largest brands, while Autograph, Tribute, Moxy, Aloft, and Element are newer lifestyle brands. Managed and franchised represented 99% of total rooms as of Dec. 31, 2025. North America makes up 61% of total rooms. Managed, franchise, and incentive fees represent the vast majority of revenue and profitability for the company.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: